JEANNE P OSBORN

Allopathic & Osteopathic Physicians|Dermatology COLORADO SPRINGS, CO NPI 1013994367

General Payments — all program years on this page

$2,545.99

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 107
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $399.10 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $299.1119
Education $99.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $133.2513
Janssen Biotech, Inc. $128.462
Regeneron Healthcare Solutions, Inc. $87.313
Amgen Inc. $27.711
UCB, Inc. $22.371

By program year

Program yearAmountRecords
2018 $654.1837
2019 $559.5722
2020 $75.314
2021 $149.411
2022 $448.2211
2023 $260.2012
2024 $399.1020

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078360486 Janssen Biotech, Inc. $99.99 02/20/2024 Education Undisputed 01/23/2026 View at CMS
1078361586 Janssen Biotech, Inc. $28.47 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160273 ABBVIE INC. $7.89 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160275 ABBVIE INC. $8.99 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160277 ABBVIE INC. $8.62 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160279 ABBVIE INC. $9.72 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160281 ABBVIE INC. $9.15 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160283 ABBVIE INC. $8.43 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160285 ABBVIE INC. $8.09 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160287 ABBVIE INC. $27.64 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160289 ABBVIE INC. $23.31 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160291 ABBVIE INC. $6.18 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160293 ABBVIE INC. $3.99 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160295 ABBVIE INC. $5.90 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105160297 ABBVIE INC. $5.34 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114128346 Regeneron Healthcare Solutions, Inc. $37.60 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114128348 Regeneron Healthcare Solutions, Inc. $36.24 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114128350 Regeneron Healthcare Solutions, Inc. $13.47 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117344422 Amgen Inc. $27.71 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143077940 UCB, Inc. $22.37 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.